Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2025-05-06 00:00:00 ET · period of report 2025-05-02 · accession 0001048477-25-000053 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-06 | 2025-04-30 | BMRN | Hubbard Cristin | EVP, Chief Commercial Off | A - Grant | $54.14 | +273 | 33.0K | +0.8% | +$14.8K | |
| 2025-05-06 | 2025-05-02 | BMRN | Hubbard Cristin | EVP, Chief Commercial Off | S - Sale | $64.92 | -273 | 32.7K | -0.8% | -$17.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-30 | A | A | 273 | $54.14 | 32,973 | D | — | — | (F1) Represents the shares acquired by the reporting person on April 30, 2025, pursuant to the issuer's Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2025-05-02 | S | D | 273 | $64.92 | 32,700 | D | — | — | (F2) Trade made pursuant to a 10b5-1 plan executed on September 13, 2024. |